Under the weight loss drug craze, stock prices are soaring! Billionaire investor: Lilly will become the first trillion dollar pharmaceutical company in history
芊芊551
发表于 2023-12-14 10:58:12
276
0
0
With the global popularity of "weight loss pills", the stock price of American pharmaceutical giant Eli Lilly has recently reached a historic high. In the eyes of billionaire investor and co-founder of Home Depot, Ken Langone, Eli Lilly's stock price prospects are bright, with the potential to become the first pharmaceutical company in history worth over a trillion dollars.
"I think Lilly will become the first pharmaceutical company in history worth trillions of dollars," Langney said in a media interview on Wednesday. "Why? Because of their research and development pipeline. May God bless (former CEO) John Lehrett. In the dark years when everything fell off a cliff, he was firmly committed to using funds for research and development and maintaining dividends."
Langney stated that the bright future of Lilly is closely related to the previous leadership of Lehlet. "He said, 'We won't cut research and development funds, we will focus our efforts to ensure that our investments receive greater returns. They did it.'"
Langny has always been a long-term shareholder of Lilly, and on Wednesday he stated that as early as 2015, Lilly had been his preferred stock. "In the 46 years I held it, including dividends, the compound annual growth rate of (the stock) reached 14.8%," he said.
The stock price surged by over 60% this year
Since this year, GLP-1 weight-loss drugs have become popular all over the world. With Mounjaro, a diabetes medicine, and Zepbound, a weight-loss drug, Lilly's share price has soared by nearly 64%, becoming one of the biggest winners of the global craze for weight-loss drugs.
Earlier this month, Lilly announced that its weight loss drug Zepbound had been launched in American pharmacies and was suitable for adults who are overly obese. The main component of Zepbund is telposide, which works by mimicking hormones, stimulating insulin release, increasing satiety, and reducing appetite. Since 2022, Lilly's Tilporide has been marketed as a drug Mounjaro for the treatment of type 2 diabetes.
In May of this year, Lilly surpassed Johnson&Johnson to become the world's largest pharmaceutical company by market value. The current market value of Lilly is approximately $567.2 billion, with more than 76% room for growth compared to the trillion dollar market value expected by Langney.
At the same time, the stock price of Danish pharmaceutical giant Novo Nordisk has surged with GLP-1 drugs such as Ozempic, and the stock has risen nearly 45% so far this year.
In stark contrast to the endless glory of Lilly and Novo Nordisk, some other pharmaceutical stocks are struggling.
Taking Pfizer as an example, the company's stock price has fallen by nearly 50% so far this year. On Wednesday, Pfizer's stock price fell after predicting that its 2024 sales may be $5 billion lower than Wall Street's expectations as revenue from COVID-19 vaccines and treatments continued to slow.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Over the past year, it has skyrocketed nearly 7 times! Can Nvidia's soaring stock price continue?
- Bitcoin once broke through $64000 in the cryptocurrency market, with over 110000 people selling out in 24 hours
- Up 96.92%! This Chinese concept brokerage stock is soaring
- Baidu Vice President Xie Guangjun: 2024 will become the first year of the explosion of domestic large-scale model industry applications
- One bottle of heavyweight new drug approved for 100000 yuan! How much impact will the soaring stock price have?
- The price reduction is effective! Apple's "Big Counterattack" on Sales in China and "Greatest Price Reduction in History" have Initiated
- NetEase Youdao CEO Zhou Feng: Integration of production and modeling will become a trend. Super App may be born at any time | Financial Interview
- Missing Nvidia's frenzy perfectly, losing $1.2 billion in "blood loss"? Sister Mu still insists that the valuation is too high!
- Apple will become the first tech giant to face accusations of new EU digital laws
- Illustration: How did the stock, bond, and foreign exchange markets perform after the Federal Reserve cut interest rates in history?
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 前天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 昨天 17:41
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 昨天 16:27
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 昨天 14:41
- 支持
- 反对
- 回复
- 收藏